Prediction of Non-sentinel Lymph Node Metastases After Positive Sentinel Lymph Nodes Using Nomograms
- PMID: 29970530
- DOI: 10.21873/anticanres.12694
Prediction of Non-sentinel Lymph Node Metastases After Positive Sentinel Lymph Nodes Using Nomograms
Abstract
Background/aim: Only 30-50% of patients with sentinel lymph node (SLN) metastases present with further axillary lymph node metastases. Therefore, up to 70% of patients with positive SLN are overtreated by axillary dissection (AD) and may suffer from complications such as sensory disturbances or lymphedema. According to the current S3 guidelines, AD can be avoided in patients with a T1/T2 tumor if breast-conserving surgery with subsequent tangential irradiation is performed and no more than two SLNs are affected. Additionally, use of nomograms, that predict the probability of non-sentinel lymph node (NSLN) metastases, is recommended. Therefore, models for the prediction of NSLN metastases in our defined population were constructed and compared with the published nomograms.
Patients and methods: In a retrospective study, 2,146 primary breast cancer patients, who underwent SLN biopsy at the University Women's Hospital in Tuebingen, were evaluated by dividing the patient group in a training and validation collective (TC or VC). Using the SLN-positive TC patients, three models for the prediction of the likelihood of NSLN metastases were adapted and were then validated using the SLN-positive VC patients. In addition, the predictive power of nomograms from Memorial Sloan Kettering Cancer Center (MSKCC), Stanford, and the Cambridge model were compared with regard to our patient collective.
Results: A total of 2,146 patients were included in the study. Of these, 470 patients had positive SLN, 295 consisted the training collective and 175 consisted the validation collective. In a regression model, three variants - with 11, 6 and 2 variables - were developed for the prediction of NSLN metastases in our defined population and compared to the most frequently used nomograms. Our variants with 11 and with 6 variables were proven to be a particularly suitable model and showed similarly good results as the published MSKCC nomogram.
Conclusion: Our developed nomograms may be used as a prediction tool for NSLN metastases after positive SLN.
Keywords: Breast cancer; nomogram; non-sentinel lymph node metastases; prediction tool; sentinel lymph node metastases.
Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Similar articles
-
Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.Arch Surg. 2011 Sep;146(9):1035-40. doi: 10.1001/archsurg.2011.201. Arch Surg. 2011. PMID: 21931000
-
Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.Int J Surg. 2013;11(7):538-43. doi: 10.1016/j.ijsu.2013.05.005. Epub 2013 May 22. Int J Surg. 2013. PMID: 23707626
-
Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study.Eur J Surg Oncol. 2010 Jan;36(1):30-5. doi: 10.1016/j.ejso.2009.05.007. Epub 2009 Jun 16. Eur J Surg Oncol. 2010. PMID: 19535217
-
Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system.Int J Clin Pract. 2008 Nov;62(11):1785-91. doi: 10.1111/j.1742-1241.2008.01887.x. Int J Clin Pract. 2008. PMID: 19143863 Review.
-
A quantitative analysis of tumour characteristics in breast cancer patients with extranodal extension in non-sentinel nodes.Breast. 2018 Apr;38:171-174. doi: 10.1016/j.breast.2018.01.003. Epub 2018 Feb 3. Breast. 2018. PMID: 29413405 Review.
Cited by
-
Residual lymph node tumour burden following removal of a single axillary sentinel lymph with macrometastatic disease in women with screen-detected invasive breast cancer.BJS Open. 2021 Mar 5;5(2):zraa022. doi: 10.1093/bjsopen/zraa022. BJS Open. 2021. PMID: 33688940 Free PMC article.
-
A new prediction nomogram of non-sentinel lymph node metastasis in cT1-2 breast cancer patients with positive sentinel lymph nodes.Sci Rep. 2024 Apr 26;14(1):9596. doi: 10.1038/s41598-024-60198-0. Sci Rep. 2024. PMID: 38671007 Free PMC article.
-
Development and validation of nomograms for predicting axillary non-SLN metastases in breast cancer patients: A retrospective analysis.Front Oncol. 2023 Mar 10;13:1096589. doi: 10.3389/fonc.2023.1096589. eCollection 2023. Front Oncol. 2023. PMID: 36969057 Free PMC article.
-
Prediction of nodal staging in breast cancer patients with 1-2 sentinel nodes in the Z0011 era.Medicine (Baltimore). 2020 Aug 28;99(35):e21721. doi: 10.1097/MD.0000000000021721. Medicine (Baltimore). 2020. PMID: 32871890 Free PMC article.
-
Development of a prediction model based on LASSO regression to evaluate the risk of non-sentinel lymph node metastasis in Chinese breast cancer patients with 1-2 positive sentinel lymph nodes.Sci Rep. 2021 Oct 7;11(1):19972. doi: 10.1038/s41598-021-99522-3. Sci Rep. 2021. PMID: 34620978 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical